Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Neogen Corporation stock

Own Neogen Corporation stock in just a few minutes.

Neogen Corporation is a diagnostics & research business based in the US. Neogen Corporation shares (NEOG) are listed on the NASDAQ and all prices are listed in US Dollars. Neogen Corporation employs 1,764 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Neogen Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NEOG – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Neogen Corporation share price

Use our graph to track the performance of NEOG stocks over time.

Neogen Corporation shares at a glance

Information last updated 2021-04-22.
52-week range$59.70 - $97.54
50-day moving average $87.18
200-day moving average $80.42
Wall St. target price$87.50
PE ratio 81.9241
Dividend yield N/A (0%)
Earnings per share (TTM) $1.16

Buy Neogen Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Neogen Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Neogen Corporation under- or over-valued?

Valuing Neogen Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Neogen Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Neogen Corporation's P/E ratio

Neogen Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 82x. In other words, Neogen Corporation shares trade at around 82x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Neogen Corporation's PEG ratio

Neogen Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.2189. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Neogen Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Neogen Corporation's EBITDA

Neogen Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $96.9 million.

The EBITDA is a measure of a Neogen Corporation's overall financial performance and is widely used to measure a its profitability.

Neogen Corporation financials

Revenue TTM $450.1 million
Operating margin TTM 17.1%
Gross profit TTM $196.3 million
Return on assets TTM 5.82%
Return on equity TTM 8.09%
Profit margin 13.66%
Book value $15.09
Market capitalisation $5.1 billion

TTM: trailing 12 months

Shorting Neogen Corporation shares

There are currently 1.5 million Neogen Corporation shares held short by investors – that's known as Neogen Corporation's "short interest". This figure is 9.4% down from 1.6 million last month.

There are a few different ways that this level of interest in shorting Neogen Corporation shares can be evaluated.

Neogen Corporation's "short interest ratio" (SIR)

Neogen Corporation's "short interest ratio" (SIR) is the quantity of Neogen Corporation shares currently shorted divided by the average quantity of Neogen Corporation shares traded daily (recently around 231566.08832808). Neogen Corporation's SIR currently stands at 6.34. In other words for every 100,000 Neogen Corporation shares traded daily on the market, roughly 6340 shares are currently held short.

However Neogen Corporation's short interest can also be evaluated against the total number of Neogen Corporation shares, or, against the total number of tradable Neogen Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Neogen Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Neogen Corporation shares in existence, roughly 30 shares are currently held short) or 0.0443% of the tradable shares (for every 100,000 tradable Neogen Corporation shares, roughly 44 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Neogen Corporation.

Find out more about how you can short Neogen Corporation stock.

Neogen Corporation share dividends

We're not expecting Neogen Corporation to pay a dividend over the next 12 months.

Have Neogen Corporation's shares ever split?

Neogen Corporation's shares were split on a 1333:1000 basis on 1 January 2018. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1333 shares. This wouldn't directly have changed the overall worth of your Neogen Corporation shares – just the quantity. However, indirectly, the new 25% lower share price could have impacted the market appetite for Neogen Corporation shares which in turn could have impacted Neogen Corporation's share price.

Neogen Corporation share price volatility

Over the last 12 months, Neogen Corporation's shares have ranged in value from as little as $59.7 up to $97.54. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neogen Corporation's is 0.4688. This would suggest that Neogen Corporation's shares are less volatile than average (for this exchange).

Neogen Corporation overview

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site